Received an article: silverberg, d.E.(2020).Chimney endovascular repair of primary mycotic aneurysms involving the paravisceral aorta.Annals of vascular surgery, 59-66.Purpose: the purpose of this study is to report an experience with chimney evar (chevar) in patients with mycotic aortic aneurysms.Method: a retrospective review of all patients treated with evar at our institution between 2009 and 2019.Conclusion: chevar is a feasible and safe treatment modality for maas involving the visceral segment.Per the article adverse events included renal failure and sepsis.
|
This complaint is based on information within an article and no specific device information has been provided.As there is insufficient details of an actual device malfunction or adverse event that occurred the complaint cannot be confirmed.A device history record (dhr) review was unable to be performed as the device product part number and lot number was not provided within the article.Conclusion: considering the design of the study, excellent technical success rate, no stent occlusion of the pgs occurred, no required reintervention due to endoleaks and the fact that no patient required explanation of the stent grafts or conversion to an open repair, one can infer that the getinge¿s advanta v12 balloon expandable covered bridging stents performed as expected.Authors emphasized that intentional occlusion of the selected visceral arteries was required to minimize the risk of gutter endoleaks in this urgent setting.H3 other text: product not available.
|